Trademark: 77880998
Word
INVITROGEN
Status
Registered
Status Code
800
Status Date
Friday, May 27, 2022
Serial Number
77880998
Registration Number
4060554
Registration Date
Tuesday, November 22, 2011
Mark Type
3000
Filing Date
Wednesday, November 25, 2009
Published for Opposition
Tuesday, November 2, 2010

Trademark Owner History
Life Technologies Corporation - Original Registrant

Classifications
9 [ Computer software used for the collection, organization, analysis, integration and communication of scientific data; computer software used to operate laboratory instruments; laboratory instruments, namely, nucleic acid sequencers and synthesizers, genetic analyzers, thermal cyclers, cytometers, protein and peptide synthesizers, mass spectrometers and chromatographs, ] laboratory instruments for preparation of nucleic acid samples [, laboratory robots ]; laboratory supplies, namely, [ racks, vials, caps, septa, needles, bottles, flasks, filters, tubes, and seals, plastic tray covers, micro plates, ] pipette tips [, reagent reservoirs, optical heat field covers, plastic cards, and plastic capillary arrays; all for scientific and research use and diagnostics use; computer software for the construction of recombinant DNA molecules in the fields of molecular biology and genetics, building of functional or restriction maps, describing recombinant molecules, and obtaining the exact nucleotide sequences of recombinant DNA molecules; and computer software for use in database management in the fields of molecular biology and genetics that may be downloaded from a global computer network and computer software for use in database management in the fields of molecular biology and genetics; laboratory instruments, namely, magnetic particle concentrator to be used with magnetic particle-based biomedical separations; apparatus for protein and nucleic acid electrophoresis. Optical filters for wavelengths of light; detectors and/or analyzers, and components thereof, of proteins, nucleic acids, cellular metabolites, carbohydrates, viruses, bacteria and eukaryotic cells not for medical diagnostic use; laboratory instrument for performing automated washing, dispensing, hybridization, and imaging of chip based sequence specific oligonucleotides; fluorometer or spectrophotometer used for detection and quantitation of DNA, RNA, protein or other analytes in solution with detachable power cord; detachable Universal Serial Bus (USB) data cord; scientific apparatus, namely, assay tubes; software for analysis or results, all for use with a fluorometer or spectrophotometer; laboratory instrument for the detection of pathogens and/or toxins in a sample; laboratory equipment, namely, apparatus in the nature of biochips for identification, detection of presence of biological or chemicals in a sample and determination of physical or chemical properties of a sample; synthesizers for making polymer arrays and replacement parts therefor, and hybridization stations for making fluidic and microfluidic devices ]
5 [ Microbiological culture media, animal blood sera, mammalian and insect cells, mammalian and insect cell culture media and cell culture reagents, all for medical diagnostic use; diagnostic biochemical and biological reagents for use in detection or treatment for medical purposes; chemical reagents for the detection of pathogens and/or toxins in veterinary samples; pharmaceuticals preparations and compositions for therapeutic use, namely, for expanding, selecting and deleting cells of the immune systems; preparations and compositions for therapeutic use, namely, for activating cells of the immune systems; pharmaceutical preparations for use in the treatment of cancer, infectious diseases and immunodeficiencies; antibody-conjugated beads, antibody-conjugated micro-beads and antibody-conjugated microspheres for promoting a therapeutic effect on the body; chemical reagents for medical purposes ]
1 [ Reagents and kits comprised of reagents for scientific or medical research use; diagnostic reagents and kits comprised of diagnostic reagents for scientific or medical research use; diagnostic reagents for clinical or medical laboratory use; cellular pathway exploration tools, namely, enzyme-linked immunosorbent assay (ELISA), kinase activity assays, protein arrays, recombinant proteins and antibodies for analysis of multiple proteins and pathways for research purposes; key human, mouse and rat markers and antibodies conjugated to other proteins, namely, cytokines and chemokines for use in flow cytometry; cell and tissue culture media for non-medical use, cell/tissue culture growth supplements in the nature of biochemicals, reagents for use in cell/tissue cultures, and cells, all for use in scientific, laboratory, and medical research; In vitro ADME cell products, namely, fresh and cryopreserved hepatocytes and liver subcellular fractions, and transporters derived from a variety of species, including human, non-human primate, dog, rat and mouse, all for scientific, laboratory or medical research; Magnetic particle-based biomedical separation systems comprising magnetizable polymer beads, the attached antibody and the magnetic particle concentrator for separating a specific selected cell population from a larger, more complex cell population. Biological and biochemical preparations, namely, reagents and kits consisting of proteins, PCR fragments, cDNA libraries, vectors, enzymes, molecules, clones, genes, cell, recombination proteins and sites, restriction enzymes, primers, plasmids, and reagents all for scientific medical research, or research use; Microbiological culture media, animal blood sera, mammalian and insect cells, mammalian and insect cell culture media and cell culture reagents, all for medical laboratory use; full line of kits consisting primarily of one or more of the following, namely, protein arrays, nucleic acids, hormones, purification supports, resins, cells, gels, probes, buffers, stains and associated reagents and devices for the expression, amplification, purification and analysis of biological samples for scientific or medical research use; fluorescent chemicals for use in scientific research; electrophoresis gel and chromatography chemicals, buffers, and solutions for scientific research; research and diagnostic biochemical and biological reagents, other than for medical or veterinary purposes, for agricultural, ecological, DNA typing, food processing and research use; reagents and assays used for detection and quantitation of DNA, RNA, protein or other analytes in solution, sold individually or in kits for research use; chemical reagents for non-medical purposes for the detection of pathogens and/or toxins in environmental samples; synthetic DNA for use in biotechnology; synthetic DNA and molecules used as DNA molecular weight standards in biotechnology fields; nucleotide arrays for scientific research; biochemical reagents for scientific research; buffers for use in analytical chemistry all for scientific and medical research use; chemicals, namely, reagents containing ligands, effector molecules and antibodies for scientific or medical research use; antibody-conjugated micro-beads and antibody-conjugated microspheres all for scientific and medical research use and for activation of immune system cells; fluorescent chemical dyes for clinical or medical laboratory use, namely, for measurement of pH in medical laboratories ]
42 [ Providing an on-line computer database featuring information in the field of scientific and medical research; consultation and research in the fields of science, technology, medicine and health, namely, nucleic acid sequencing, analysis and synthesis of oligonucleotides and other molecules for others for use in life science research and biotechnology research; computer services, namely, providing temporary use of on-line non-downloadable software for accessing and analyzing information in the field of science, technology, medicine, health and public policy; medical, research and laboratory diagnostic services in the field of nucleic acid sequencing, analysis and synthesis of oligonucleotides and other molecules for others for use in life science research and biotechnology research; product development for others; laboratory services, namely, nucleic acid sequencing, synthesis and analysis, analysis and synthesis of oligonucleotides and other molecules for others for use in life science research and biotechnology research; installation, maintenance and repair of computer software for scientific, research, medical, and diagnostic use; nucleic acid analysis; genetic research, namely, gene discovery; genetic disease research, genomics and gene expression research and development; pharmacokinetic research services; proteomics research services; gene identification, gene cloning, gene expression, gene mapping, electrophoresis, protein purification and analysis, and protein interaction detection, all for scientific and medical research purposes; medical and scientific research; medical and scientific research for the development and commercialization of cell-based therapeutic immune system stimulators and enhancers to treat cancer and infectious diseases; technical research and consultation services related thereto in the fields of pharmaceuticals, medicine, biological sciences, immunotherapy, and medical devices; technical consultation services in the fields of development of pharmaceutical preparations and medicines, biological sciences, immunotherapy, and troubleshooting in the nature of diagnosing problems with medical devices; development of new products in the fields of pharmaceuticals, medicine, biological sciences, immunotherapy, and medical devices for others; medical laboratory services; research and development for new immunotherapy products for others; biopharmaceutical research and development; scientific research services; medical laboratory testing and diagnostic services for others in the fields of science and research related thereto; scientific research, namely, developing customized microbiological, mammalian, and insect culture media, media formulations, and cell culture reagents, and evaluating culture media for others; contract laboratory services, namely, drug-drug interaction studies, drug metabolism studies and hepatotoxicity studies, focused primarily on enzyme induction and inhibition, reaction phenotyping, metabolite stability and profiling, and P-gp assays and consulting services related thereto ]
The mark consists of a stylized DNA strand or "double helix" on a shaded circular background with a shaded circle above it followed by the word "INVITROGEN" in lowercase letters.
IN VITRO GENE
Color is not claimed as a feature of the mark.

Trademark Events
May 27, 2022
Notice Of Acceptance Of Sec. 8 - E-Mailed
May 27, 2022
Registered And Renewed (First Renewal - 10 Yrs)
May 27, 2022
Registered - Sec. 9 Granted/Check Record For Sec. 8
May 27, 2022
Registered - Partial Sec. 8 (10-Yr) Accepted
May 19, 2022
Teas Section 8 & 9 Received
Nov 22, 2020
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
Dec 20, 2017
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Dec 20, 2017
Registered - Partial Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Dec 15, 2017
Case Assigned To Post Registration Paralegal
Nov 21, 2017
Teas Section 8 & 15 Received
Nov 22, 2016
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jul 23, 2014
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 23, 2014
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 22, 2011
Registered-Principal Register
Oct 19, 2011
Notice Of Acceptance Of Statement Of Use E-Mailed
Oct 18, 2011
Law Office Registration Review Completed
Oct 18, 2011
Allowed Principal Register - Sou Accepted
Oct 18, 2011
Notice Of Approval Of Extension Request E-Mailed
Oct 17, 2011
Statement Of Use Processing Complete
Oct 17, 2011
Use Amendment Filed
Oct 17, 2011
Sou Extension 2 Granted
Oct 14, 2011
Sou Extension 2 Filed
Oct 14, 2011
Teas Statement Of Use Received
Oct 14, 2011
Teas Extension Received
Aug 2, 2011
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 2, 2011
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 30, 2011
Notice Of Approval Of Extension Request E-Mailed
Jun 29, 2011
Sou Extension 1 Granted
Jun 27, 2011
Sou Extension 1 Filed
Jun 29, 2011
Case Assigned To Intent To Use Paralegal
Jun 27, 2011
Teas Extension Received
Feb 1, 2011
Teas Change Of Correspondence Received
Dec 28, 2010
Noa E-Mailed - Sou Required From Applicant
Nov 2, 2010
Official Gazette Publication Confirmation E-Mailed
Nov 2, 2010
Published For Opposition
Sep 25, 2010
Law Office Publication Review Completed
Sep 25, 2010
Assigned To Lie
Sep 17, 2010
Approved For Pub - Principal Register
Sep 16, 2010
Teas/Email Correspondence Entered
Sep 16, 2010
Correspondence Received In Law Office
Sep 16, 2010
Teas Response To Office Action Received
Aug 4, 2010
Notification Of Non-Final Action E-Mailed
Aug 4, 2010
Non-Final Action E-Mailed
Aug 4, 2010
Non-Final Action Written
Jul 22, 2010
Teas/Email Correspondence Entered
Jul 21, 2010
Correspondence Received In Law Office
Jul 21, 2010
Teas Response To Office Action Received
Jan 21, 2010
Notification Of Non-Final Action E-Mailed
Jan 21, 2010
Non-Final Action E-Mailed
Jan 21, 2010
Non-Final Action Written
Jan 19, 2010
Assigned To Examiner
Dec 2, 2009
Notice Of Design Search Code Mailed
Dec 1, 2009
New Application Office Supplied Data Entered In Tram
Nov 28, 2009
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24